Chen Fang, Yang Peiyan, Zhu Jiuling
School of Modern Agriculture and Biotechnology, Ankang University, Ankang 725000, Shaanxi, China.
Gene Therapy Laboratory, College of Life Sciences, Shaanxi Normal University, Xi'an 710062, Shaanxi, China.
Sheng Wu Gong Cheng Xue Bao. 2018 Oct 25;34(10):1679-1692. doi: 10.13345/j.cjb.180033.
In order to study the molecular mechanism and physiological significance of the interaction between PGRN and Rev-erbβ, the PGRN gene in HEK293 (Rev-erbβ-/-) marked as C3-6 cell lines was knocked out by CRISPR/Cas9 system to generate the Rev-erbβ and PGRN double genes knockout HEK293 cell lines. First, four sgRNAs were designed for PGRN gene, and PGRN sgRNA2 and sgRNA3 with the higher activity were used to construct the Lentiviral vector, pLenti/CMV-Loxp-Cas9-sgRNA2-U6-sgRNA3-U6-Loxp-EF1α-Puro. Then, the lentivirus vector carrying Cas9 and double PGRN sgRNA were used to infect HEK293 C3-6 cells. Through drug screening, cloning and sequencing, we obtained the monoclonal HEK293 (Rev-erbβ-/-; PGRN-/-) marked as C3-6/23 cell lines. Using qRT-PCR and Western blotting, we detected PGRN mRNA and protein expression in C3-6/23 cell lines. Finally, genetic complementation was used to study the effect of PGRN-mediated Rev-erbβ on the regulation of the target gene promoter transcriptional activity in the C3-6/23 cell lines. In HEK293 C3-6/23 cell lines, the two DNA chains of PGRN gene were both deletion mutagenesis, and the expression mRNA and protein of PGRN did not reach the detection level. At the same time, the interaction between PGRN and Rev-erbβ enhanced the regulation of Rev-erbβ on the transcription of target gene promoter in the cell lines. Using CRISPR/Cas9 system, we successfully constructed the double knockout HEK293 (Rev-erbβ-/-; PGRN-/-) monoclonal cell lines. The study found that PGRN could affect Rev-erbβ on the regulation of target gene promoter transcription in the C3-6/23 cell lines; however, the mechanism of PGRN involvement in mediating Rev-erbβ in transcriptional regulation remains to be further studied.
为了研究PGRN与Rev-erbβ相互作用的分子机制及生理意义,利用CRISPR/Cas9系统敲除HEK293(Rev-erbβ-/-)中标记为C3-6细胞系的PGRN基因,构建Rev-erbβ和PGRN双基因敲除的HEK293细胞系。首先,针对PGRN基因设计4条sgRNA,选取活性较高的PGRN sgRNA2和sgRNA3构建慢病毒载体pLenti/CMV-Loxp-Cas9-sgRNA2-U6-sgRNA3-U6-Loxp-EF1α-Puro。然后,用携带Cas9和双PGRN sgRNA的慢病毒载体感染HEK293 C3-6细胞。通过药物筛选、克隆及测序,获得标记为C3-6/23细胞系的单克隆HEK293(Rev-erbβ-/-;PGRN-/-)。运用qRT-PCR和蛋白质免疫印迹法检测C3-6/23细胞系中PGRN的mRNA和蛋白表达。最后,采用基因互补研究PGRN介导的Rev-erbβ对C3-6/23细胞系中靶基因启动子转录活性调控的影响。在HEK293 C3-6/23细胞系中,PGRN基因的两条DNA链均发生缺失突变,PGRN的mRNA和蛋白表达未达检测水平。同时,PGRN与Rev-erbβ的相互作用增强了Rev-erbβ对细胞系中靶基因启动子转录的调控。利用CRISPR/Cas9系统,成功构建双敲除HEK293(Rev-erbβ-/-;PGRN-/-)单克隆细胞系。研究发现,PGRN可影响Rev-erbβ对C3-6/23细胞系中靶基因启动子转录的调控;然而,PGRN参与介导Rev-erbβ转录调控的机制仍有待进一步研究。